Session: Medications and Diagnostic Tools as Aids and Barriers to Care
5057.0: Wednesday, November 19, 2003: 8:30 AM-10:00 AM
Medications and Diagnostic Tools as Aids and Barriers to Care
Learning Objectives: Refer to the individual abstracts for learning objectives
See individual abstracts for presenting author's disclosure statement and author's information.
Board 1An assessment of the effectiveness of telemedicine for improving compliance in the treatment of schizophrenia
J. Gary Linn, PhD, James Harris, DNS, Herbert Meltzer, MD
Board 2Comparison of Olanzapine versus Quetiapine in the Treatment of Hospitalized Patients with Schizophrenia
Peter F. Wang, MD, PhD, Zhongyun Zhao, PhD
Board 3Use of Psychotherapeutic Medications among Children in Foster Care
Elizabeth T Momany, PhD, Beth R. Troutman, PhD, Gary R. Gaffney, MD, Sharashchandr S. Shetty, PhD, Peter C. Damiano, DDS, MPH, Edward L. Schor, MD, Margaret C. Tyler, MSW
Board 4Impact of less costly, focused reviews in emergency psychiatric services
Cynthia L. Arfken, PhD, Lori Lackman Zeman, PhD, Lindsay Yeager, Aja Temple, Serena Roth
Board 5Out-of-Pocket Prescription Drug Expenditures among Elderly with Mental Illness
Michelle Kennedy, BA, Ayse Akincigil, MA, Stephen Crystal, PhD, Usha Sambamoorthi, PhD
Board 6Results of a trial of the Diagnostic Interview Schedule-IV in American Sign Language for use with individuals who are deaf
Marjorie F. Goldstein, PhD, Elizabeth A. Eckhardt, CSW, Annie Steinberg, MD
Board 7Race and differential diagnosis
Estina Thompson, PhD, MPH, Harold Neighbors, PhD, Steven J. Trierweiler, PhD, Cheryl Munday, PhD, Stacy Cohen
Withdrawn -- Profiling murderers with the MMPI-2 in court
Tracy O'Connor Pennuto, MA
Organized by:Mental Health

The 131st Annual Meeting (November 15-19, 2003) of APHA